Abstract:Background Nonadherence to antihypertensive medications is the leading cause of poor blood pressure control and thereby cardiovascular diseases and mortality worldwide. Methods and Results We investigated the global epidemiology, regional differences, and trend of antihypertensive medication nonadherence via a systematic review and meta‐analyses of data from 2010 to 2020. Multiple medical databases and clinicaltrials.gov were searched for articles. Observational studies reporting the proportion of patients with anti‐hypertensive medication nonadherence were included. The proportion of nonadherence, publication year, year of first recruitment, country, and health outcomes attributable to antihypertensive medication nonadherence were extracted. Two reviewers screened abstracts and full texts, classified countries according to levels of income and locations, and extracted data. The Joanna Briggs Institute prevalence critical appraisal tool was used to rate the included studies. Prevalence meta‐analyses were conducted using a fixed‐effects model, and trends in prevalence were analyzed using meta‐regression. The certainty of evidence concerning the effect of health consequences of nonadherence was rated according to Grading of Recommendations, Assessment, Development and Evaluations. A total of 161 studies were included. Subject to different detection methods, the global prevalence of anti‐hypertensive medication nonadherence was 27% to 40%. Nonadherence was more prevalent in low‐ to middle‐income countries than in high‐income countries, and in non‐Western countries than in Western countries. No significant trend in prevalence was detected between 2010 and 2020. Patients with antihypertensive medication nonadherence had suboptimal blood pressure control, complications from hypertension, all‐cause hospitalization, and all‐cause mortality. Conclusions While high prevalence of anti‐hypertensive medication nonadherence was detected worldwide, higher prevalence was detected in low‐ to middle‐income and non‐Western countries. Interventions are urgently required, especially in these regions. Current evidence is limited by high heterogeneity. Registration URL: www.crd.york.ac.uk/prospero/; Unique identifier: CRD42021259860. Nonstandard Abbreviations and Acronyms MMAS Morisky Medication Adherence Scale MPR medication possession ratio WHO World Health Organization Clinical Perspective What Is New? Anti‐hypertensive medication nonadherence was common globally (27%–40%), was more prevalent in low‐ to middle income and non‐Western countries, and did not improve between 2010 and 2020. What Are the Clinical Implications? Policymakers and clinicians should incorporate validated methods (eg, validated questionnaires, medication procession ratio, pill counting, electronic pills or pillbox, and biochemical detection by drug assays) into health care systems to routinely detect anti‐hypertensive medication nonadherence. Once detected, clinicians could conceptualize the reasons for nonadherence, using the World Health Organization model, and manage them accordingly. Medication adherence is defined as the "extent to which patients take their medication as prescribed." 1 , 2 Although hypertension is one of the most common chronic conditions and a leading cause of death globally, 3 medication nonadherence among patients with hypertension is highly prevalent. Up to 50% of patients stop taking their prescribed antihypertensive medications within 1 year of initiation. 4 The high prevalence of antihypertensive medication nonadherence has contributed to poor blood pressure (BP) control worldwide. Accordingly, optimal control of BP is attained in less than one‐third and one‐tenth of patients with hypertension in high‐income and low‐ to middle‐income countries, respectively. 1 , 3 This poor control has consequently led to a high global burden of cardiovascular diseases, chronic kidney disease, dementia, and mortality. The World Health Organization (WHO) has provided a conceptual framework to explain the multifactorial reasons underlying antihypertensive medicati -Abstract Truncated-

Adherence to antihypertensive medication and its predictors among non-elderly adults in Japan

Medication adherence and associated factors in newly diagnosed hypertensive patients in Japan: the LIFE study

[Study on the Compliance of Antihypertensive Drugs in Patients with Hypertension].

Evaluation of Medication Adherence Among Prevalent Users in Hypertension, Dyslipidemia, and Diabetes Using Health Insurance Claims: A Population-Based Cohort Study in Japan

A11823 Analysis of Treatment Adherance to Antihypertensive Drugs in Chinese Hypertensive Patients

Analysis of Adherence to Antihypertensive Drugs in Chinese Patients with Hypertension: A Retrospective Analysis Using the China Health Insurance Association Database.

Factors associated with suboptimal adherence to antihypertensive medication: Cross-sectional study using nationally representative databases

Antihypertensive medication persistence and adherence among non-Hispanic Asian US patients with hypertension and fee-for-service Medicare health insurance

Predictors of poor medication adherence of older people with hypertension

Determinants of adherence among patients with hypertension

Medication Adherence of People Living with HIV in Japan-A Cross-Sectional Study

Adherence to antihypertensives in the United States: A comparative meta‐analysis of 23 million patients

The role of ambulatory blood pressure monitoring in enhancing medication adherence among patients with newly diagnosed hypertension: an analysis of the National Health Insurance cohort database

Hypertension Medication and Medicare Beneficiaries: Prescription Drug Coverage Satisfaction and Medication Non-Adherence among Older Adults

GLOBAL BURDEN, REGIONAL DIFFERENCES, TRENDS, AND HEALTH CONSEQUENCES OF MEDICATION NON-ADHERENCE IN PATIENTS WITH HYPERTENSION DURING 2010-2020: A SYSTEMATIC REVIEW AND META-ANALYS

Medication adherence and associated factors among elderly hypertension patients with uncontrolled blood pressure in rural area, Northeast Thailand

Effect of medication adherence on blood pressure control and risk factors for antihypertensive medication adherence.

Patient, family, and community factors associated with medication adherence among people with hypertension or diabetes: A cross-sectional analysis

Association between cognitive impairment and poor antihypertensive medication adherence in elderly hypertensive patients without dementia

Global Burden, Regional Differences, Trends, and Health Consequences of Medication Nonadherence for Hypertension During 2010 to 2020: A Meta‐Analysis Involving 27 Million Patients

Current prescription status of antihypertensive drugs in Japanese patients with hypertension: Analysis by type of comorbidities